The largest database of trusted experimental protocols

5 protocols using anti cd44 pe

1

Characterization of Breast Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the characterization of BCSCs, cell lines MCF-7, MDA-MB-231 and SK-BR-3 were grown in 2D culture as monolayer and in 3D culture as mammospheres in suspension (only the positive subpopulation). These mammospheres were obtained by sorting with the Aldefluor Kit (see Section 4.3.1.). After five days, cell lines were irradiated at 0, 2 and 6 Gy and characterization was performed 24 h after irradiation. The markers determined were the specific human antibodies anti-CD24 (APC) and anti-CD44 (PE) (Miltenyi Biotec, Bergisch Gladbach, Germany) and the enzyme ALDH1 activity was also detected using the Aldefluor Kit (StemCell Technologies, Vancouver, BC, Canada). Samples were analyzed on a BD FACSCanto II flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Three independent experiments were run in triplicate. The mean value for each experiment was calculated by averaging the triplicates (n = 3).
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Cancer Stem Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect the expression of cancer stem cell markers, the following antibodies were used: anti-CD44-PE, anti-CD24-APC, anti-ESA-PE-Vio770, IgG1-PE, IgG1-APC, IgG1-PE-Vio770 (Miltenyi). Cells were harvested with trypsin-EDTA to produce a single cell suspension. The cells were pelleted by centrifugation, washed twice with PBS and incubated with the antibody for 10 min in the dark at 4℃. The respective isotype control antibodies were used at the same concentrations according to the manufacturer's instructions. After washing twice with PBS, samples were resuspended in 500 μl PBS and analyzed on a flow cytometer (FACSAriaII, USA). Cells were routinely sorted twice, and the cells were reanalyzed for the purity, which typically was >97%. Data were analyzed with BD FACS Diva software.
+ Open protocol
+ Expand
3

Flow Cytometric Analysis of CSC Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the flow cytometric analysis of CSC markers, cells were digested into single-cell suspensions and washed with PBS. Then, 1 × 106 cells were resuspended in 100 μL of PBS containing 0.5% BSA and 10 μL of fluorophore-conjugated primary antibody anti-CD133-phycoerythrin (PE) (Miltenyi Biotec, Germany) and anti-CD44-PE (Miltenyi Biotec, Germany) for 10 min in the dark at 4°C. Afterward, the tubes were removed by centrifugation and washed twice with 500 μL of PBS buffer. Next, cells were suspended in 200 μL of PBS and analyzed using a fluorescence-activated cell sorting (FACS) Vantage SE (BD Biosciences, Franklin Lakes, USA).
+ Open protocol
+ Expand
4

Multi-Marker Flow Cytometry Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies anti-CD31 PE-Cy7, anti-CD18 PE or APC, anti-CD51 FITC, anti-CD64 FITC, anti-CD14 FITC, PE or PerCP-Cy5.5, anti-CD66abce FITC, anti-CD34 VioBlue®, anti-CD38 FITC, anti-CD44 PE, anti-CD45 VioBlue® or APC-Vio770, anti-CD3 FITC or PerCP-Cy5.5, anti-CD20 FITC or PerCP-Cy5.5, anti-CD15 FITC, anti-CD16 PerCP-Cy5.5, anti-HLA-DR VioBlue®, anti-CD86 VioBlue®, anti-CD80 VioBlue®, anti-CD90 FITC and PerCP-Cy5.5, anti-CD133 APC, anti-CD138 PE, anti-CD140a PE, anti-CD146 FITC, and anti-MSCA-1 PE were from Miltenyi Biotec. Anti-STRO-1 AlexaFluor® 647, anti-CD73 PE-Cy7, anti-CD105 PerCP-Cy5.5, anti-CD140b PE, anti-CD56 APC, anti-CD309 PerCP-Cy5.5, anti-CD115, anti-CD144 PE, anti-SSEA-3 FITC, and anti-SSEA-4 FITC were from BioLegend (San Diego, CA). Anti-CD271 PE, anti-CD11b PE, anti-CD11c PE, and anti-CD36 APC were from BD Biosciences (San Jose, CA).
+ Open protocol
+ Expand
5

Flow Cytometry Analysis of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs at passage three were analyzed by flow cytometry with a CytoFLEX flow cytometer (Beckman Coulter, Fullerton, CA, USA), collecting at least 10,000 events. Antibodies used to confirm ASC phenotype [15 (link)] were: anti-CD44-PE (Cat# 130-110-293), CD90-FITC (clone REA897), CD105-PerCP-Vio700 (clone REA794), CD45-PE Vio770 (clone REA747) (Miltenyi Biotec, Bergisch Gladbach, Germany). Doublets were removed from analysis gating events on FSC-H and FSC-A plot.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!